Sort Results:

List of Materials

Document
A High-Throughput, Accurate Mass Approach for Plasma Protein Binding Analysis Using SPE/TOF-MS

An ultafast SPE/TOF/MS method was developed to analyze plasma protein binding assay samples at a rate of 9 sec per sample. This ultrafast, high resolution approach may be useful for the analysis of other in vitro ADME assays

Agilent Technologies

Presenter: Agilent Technologies

Document
Accelerating Drug Discovery for Alzheimer’s Disease: Best Practices for Preclinical Animal Studies


The Alzheimer’s Drug Discovery Foundation (ADDF) partnered with Charles River to convene a panel of academic, industry and government scientists to make recommendations on best practices for animal studies testing...

Charles River

Presenter: Charles River

Document
Big data in drug safety

Safety and efficacy information on drugs shall be communicated to all stakeholders, including physicians, patients, insurers and investors, in a format that allows objective assessment of real value of the intervention compared to other treatments....

ARETE-ZOE, LLC

Presenter: Veronika Valdova

Document
Case Study: The Discovery of Telaprevir (VX-950, Incivek) for the treatment of Hepatitis C

This Case study shows the drug discovery process of Telaprevir for Hepatitis. IT discusses the background of Hepatitis, and the basic information on Hepatitis C, Preclinical studies, Clinical studies, critical findings, timeline to approval and the...

Brain Science Institute NeuroTranslational Drug Discovery Program

Johns Hopkins University

Presenter: Dana Ferraris, Ph.D., M.B.A.

Document
Generic Pharmaceutical Drug Solutions Guide

Agilent Technologies delivers unique, comprehensive solutions based on industry-leading technology, enabling optimal resource utilization so you can improve productivity and be first to market.

Agilent Technologies

Presenter: Agilent Technologies

Document
Global Pharma Primer, Syllabus and Road Map

The material included in these modules serves many interests by facilitating understanding of construct, dynamics, and influences affecting regulatory policies and corporate decision-making that ultimately determine access, availability, and...

ARETE-ZOE, LLC

Presenter: ARETE-ZOE

Document
Molecular Subtypes in Glioblastoma Multiforme: Integrated Analysis Using Agilent GeneSpring and Mass Profi ler Professional Multi-Omics Software

Agilent GeneSpring and Mass Profi ler Professional (MPP) software was used to perform integrated multi-omics analysis of mRNA expression, miRNA expression, protein expression, and copy number aberration (CNA) associated with glioblastoma multiforme...

Agilent Technologies

Presenter: D. Renu, P. Aggarwal, S. Cherukuri, P. Tata, V. Bhat, C. Livi, M. Rosenberg, M. Al-Gizawiy, K. Schmainda, S. Mirza